Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 19(3): 461-6, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25720719

RESUMEN

OBJECTIVE: The Crimean-Congo haemorrhagic fever virus (CCHFV), which is transmitted by the ticks of Hyalomma spp. in general and H. marginatumin particular, can cause severe disease in humans, with mortality rates of 3-30%. Other than from the bites of infected ticks, CCHFV can also be transmitted through contact with patients with the acute phase of infection or contact with blood or tissues from viraemic livestock.  Outbreaks of human cases of haemorrhagic manifestations have been documented since 1945 and described in parts of Africa, Asia, Eastern Europe and the Middle East and most recently India in 2011. In addition, serological evidence of the disease has been reported in some countries where no human cases were reported. As regional neighbours China and India have been affected by this virus, this study was conducted to determine the seroprevalence of CCHFV among Orang Asli population of Malaysia as the most at risk people who residing in the deep forests. PATIENTS AND METHODS: A total of 682 serum samples were collected from the Orang Asli population residing in eight states in peninsular Malaysia and analysed for the presence of anti-CCHFV immunoglobulin G (IgG) using a commercial enzyme-linked immunosorbent assay kit. RESULTS: The study subjects comprised 277 (40.6%) men and 405 (59.4%) women. However, anti-CCHFV IgG was detected in only one female serum sample (0.1%). The presence of anti-CCHFV IgG could not be correlated to age or sex from these findings. CONCLUSIONS: The results of this screening survey showed that the seroprevalence of the anti-CCHFV IgG among Malaysia's Orang Asli population is too low for detection or totally negative compared with that in neighbouring countries, such as India and China.


Asunto(s)
Virus de la Fiebre Hemorrágica de Crimea-Congo/metabolismo , Fiebre Hemorrágica de Crimea/sangre , Vigilancia de la Población , Informe de Investigación , Mordeduras de Garrapatas/sangre , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Animales , Niño , Preescolar , Ensayo de Inmunoadsorción Enzimática/métodos , Femenino , Fiebre Hemorrágica de Crimea/diagnóstico , Fiebre Hemorrágica de Crimea/etnología , Humanos , Malasia/etnología , Masculino , Persona de Mediana Edad , Estudios Seroepidemiológicos , Mordeduras de Garrapatas/diagnóstico , Mordeduras de Garrapatas/etnología , Garrapatas , Adulto Joven
4.
G Ital Dermatol Venereol ; 148(6): 687-91, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24442052

RESUMEN

Phytomedicine has been successfully used in dermatology horizon for thousands of years. Jojoba (Simmondsia chinensis) is a long-lived, drought resistant, perennial plant with interesting economic value as it is processed for liquid wax production. The jojoba plant produces esters of long-chain alcohols and fatty acids (waxes) as a seed lipid energy reserve. The liquid wax is an important substrate for a variety of industrial applications and is used in skin treatment preparations. The oil from the jojoba plant is the main biological source of wax esters and has a multitude of potential applications. The review of literatures suggest that jojoba has anti-inflammatory effect and it can be used on a variety of skin conditions including skin infections, skin aging, as well as wound healing. Moreover, jojoba has been shown to play a role in cosmetics formulas such as sunscreens and moisturizers and also enhances the absorption of topical drugs. The intention of the review is to summarize the data regarding the uses of jojoba in dermatology for readers and researchers.


Asunto(s)
Antiinflamatorios/uso terapéutico , Dermatología/tendencias , Magnoliopsida , Extractos Vegetales/uso terapéutico , Envejecimiento de la Piel/efectos de los fármacos , Enfermedades de la Piel/tratamiento farmacológico , Ceras/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Antiinflamatorios/administración & dosificación , Cosméticos/administración & dosificación , Cosméticos/uso terapéutico , Humanos , Extractos Vegetales/administración & dosificación , Protectores Solares/administración & dosificación , Protectores Solares/uso terapéutico , Resultado del Tratamiento
5.
Transplant Proc ; 38(9): 2923-5, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17112866

RESUMEN

Polyoma virus nephropathy occurs in 3% to 4% of renal transplant recipients, causing graft loss in 50% of cases. In this study we sought to identify the incidence of polyoma virus infection among our transplanted patients on the basis of age, sex, creatinine level, and postoperative period. During this study the 1086 urine samples collected from 362 patients were centrifuged and stained with the Papaniclaou method. All slides were classified as negative or positive (>1 decoy cell/sample). Among 1086 urine cytologies from 241 men and 121 women, decoy cells were identified in 26.6% (96) of patients, including 29.9% (n = 72) men and 20% (n = 24) women. The incidence of decoy cells (26.6%) was increased among men and associated with a longer transplantation period (P < .05). A significant relation was detected between older age and positive urine cytology. The patients with positive urine cytology for decoy cells showed a greater incidence of abnormal plasma creatinine values (26%) compared with patients showing a negative urine cytology (13.5%). In conclusion, identification of cells with viral inclusions (decoy cells) may help with the diagnosis of viral replication or active infection, therefore, routine urine cytology may be used as screening method for the detection of polyoma virus infection.


Asunto(s)
Trasplante de Riñón/efectos adversos , Infecciones por Polyomavirus/orina , Complicaciones Posoperatorias/virología , Femenino , Humanos , Incidencia , Masculino , Infecciones por Polyomavirus/epidemiología , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/orina , Prevalencia , Estudios Retrospectivos , Orina/citología
6.
J Dermatolog Treat ; 13(2): 73-6, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12060505

RESUMEN

BACKGROUND: A number of effective topical therapies are available for the treatment of tinea versicolor (TV). However, topical antifungals are difficult to apply to a large body surface area and for this reason TV is perhaps more easily treated with systemic agents. METHODS: A total of 128 patients with TV, aged 15-55 years, were entered into a randomized, double-blind, clinical trial comparing the efficacy and tolerance of two regimens of oral treatment for TV. The patients were randomly divided in two groups: group 1 received two 150 mg capsules of fluconazole in a single dose repeated weekly for 2 weeks; and group 2 received two 200 mg tablets of ketoconazole in a single dose repeated weekly for 2 weeks. Diagnosis of TV was made clinically by direct KOH preparation and Wood's lamp examination. RESULTS: Of 128 patients, 100 completed the study and no major side-effects were noted between the two treatment regimens. Results of the study showed no significant differences in efficacy, safety and tolerability between the two treatment regimens. The maximal cure rate was achieved at 8 weeks from the start of treatment and decreased slightly afterwards. CONCLUSIONS: Fluconazole and ketoconazole demonstrated similar efficacy in the treatment of TV. We also demonstrated a lack of correlation between mycological cure and hypopigmentation at the end of treatment (2 weeks) and the usefulness of Wood's lamp examination in detecting cure of TV.


Asunto(s)
Antifúngicos/administración & dosificación , Fluconazol/administración & dosificación , Cetoconazol/administración & dosificación , Tiña Versicolor/tratamiento farmacológico , Administración Oral , Adolescente , Adulto , Antifúngicos/efectos adversos , Método Doble Ciego , Esquema de Medicación , Exantema/inducido químicamente , Fatiga/inducido químicamente , Femenino , Fluconazol/efectos adversos , Estudios de Seguimiento , Cefalea/inducido químicamente , Humanos , Cetoconazol/efectos adversos , Malassezia/aislamiento & purificación , Masculino , Persona de Mediana Edad , Seguridad , Tiña Versicolor/microbiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA